While testosterone is responsible for male characteristics like muscle mass and body hair, oestrogen regulates fat distribution and the growth of breast tissue. In hypogonadal patients, treatment with T may lead to regression by producing androgens, although in some patients T may get aromatized to E2, resulting in further breast enlargement.2,11 Dialysis or re-feeding related gynecomastia is usually self-limited and reassurance may be sufficient. Local tissue factors in the breast can also be important; for example, increased aromatase activity that can cause excessive local production of estrogen, decreased estrogen degradation and changes in the levels or activity of estrogen or androgen receptors. One of the primary causes of gynecomastia is hormonal imbalance, particularly an increase in estrogen levels relative to testosterone. Gynecomastia refers to the enlargement of breast tissue in males, which can be a source of embarrassment and self-consciousness for many individuals. Men are less likely to be diagnosed as having breast cancer at an early stage, but diagnosis at the preinvasive (in situ) stage has increased since the 1980s,18 perhaps owing to the heightened awareness of patients and clinicians.
Gynecomastia may also develop because of breast cancer or tumors in the testicle, adrenal gland, or pituitary gland, since these conditions can disrupt hormone balance. In some cases, medications may be prescribed to address hormonal imbalances and reduce the size of breast tissue. Characterized by the growth of glandular breast tissue, true gynecomastia is the most common type of the condition. This shift in hormone levels can result in an estrogen-to-testosterone imbalance, contributing to gynecomastia. The most evident symptom of gynecomastia is the enlargement of breast tissue.
A 33 year old man mentioned fatigue; headaches; painful, enlarged breasts; and impotence. Overall survival is shorter in men, possibly because they tend to be older and have more comorbid conditions. Men usually are offered adjuvant hormone therapy with tamoxifen 20 mg/day for five years, as several retrospective studies have shown improved survival.24 If the tumour has adverse features, adjuvant systemic therapy (chemotherapy or HER2 antibody trastuzumab, or both) should be offered. Complications include haematoma, seroma, infection, sensory changes, pain, breast asymmetry, skin redundancy, and scarring.22 23 The most common complication is a poor cosmetic outcome.
Prolactin induced suppression of the gonadotrophin releasing hormone pulse generator may have contributed. Suppression of the hypothalamic-pituitary-gonadal axis can persist for months to years after prolonged exposure to exogenous androgen. Levels of thyroid stimulating hormone, free thyroxine, morning cortisol, and adrenocorticotrophic hormone were normal. He had been a heavy user of androgen containing substances for muscle enhancement until three months previously.
Management is extrapolated from female breast cancer and from case series in single institutions. No prospective studies have been done of male breast cancer. Goals of surgery include removing abnormal breast tissue, restoring the normal male breast contour, and reducing pain. Almost no lobular tissue exists in normal adult male breast tissue.
If differentiating between gynecomastia and breast cancer cannot be achieved using physical and imaging findings, a percutaneous biopsy should be taken. Heterogeneous inversion or polymorphism of the p450 aromatase gene leads to increased aromatase activity in peripheral tissues, resulting in elevated estrogen levels. Gynecomastia in patients with cirrhosis or liver disease is caused by increased production of androstenedione (A) from adrenal glands, increased aromatization of A to E1, increased conversion of E1 to E2, decreased clearance of adrenal androgens from the liver and increased SHBG, which leads to a decrease in free T levels. Medications have been reported to cause up to 25% of cases of gynecomastia and they can be categorized by their hormone-like action.6,10 Type 1 medications act like estrogens and include diethylstilbestrol (DEB), oral contraceptives, phytoestrogens, digitalis and estrogen-containing cosmetics.
In addition, increased use of anabolic steroids and environmental contamination with xenoestrogens or estrogen-like substances may stimulate glandular proliferation in male breast tissue. Gynecomastia is the benign enlargement of male breast glandular tissue and is the most common breast condition in males. It’s important to note that male breast cancer can also cause a lump in your breast tissue.
As men age, testosterone levels may naturally decline while estrogen levels remain relatively stable. There are several factors and conditions that can contribute to hormonal imbalances and thus trigger gynecomastia. Read further to learn the gynecomastia symptoms, risk factors, secondary prevention, and various gynecomastia treatments. It usually presents as a soft, symmetrical swelling of the breast tissue, which can sometimes be tender or painful. However, TRT not always effective and can sometimes worsen gynecomastia if the excess testosterone converted into estrogen.
The rate of breast cancer in Japanese men exposed to nuclear fallout was threefold greater than in non-exposed men.14 Population based US tumour registries show that rates are highest in African-American men, intermediate in non-Hispanic Caucasian men and Asian-Pacific Islanders, and lowest in Hispanic men.10 Male breast cancer can occur at any age but mean age is 65 years. Male breast cancer represents about 1% of all cases of breast cancer, but in sub-Saharan Africa 7-14% of breast cancer cases occur in men. Lung and hepatic tumours can produce enough systemic human chorionic gonadotrophin to increase Leydig cell testosterone secretion, which is readily converted to oestrogen through increased aromatase activity.